Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial

por Martinez, Fernando J., Afzal, Amna Sadaf, Smith, Jaclyn A., Ford, Anthony P., Li, Jerry Jing, Li, Yuping, Kitt, Michael M.
Publicado 2021

The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough

por McGarvey, Lorcan, Sher, Mandel, Shvarts, Yury Grigorievich, Lu, Susan, Wu, Wen-Chi, Xu, Ping, Schelfhout, Jonathan, La Rosa, Carmen, Nguyen, Allison Martin, Reyfman, Paul A., Afzal, Amna Sadaf
Publicado 2023